Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.
Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.
复制标题
使用气相色谱-质谱法对大脑和生物体液中的伊博加因和邻去甲基化代谢物进行鉴定和定量。
DOI:
10.1093/jat/19.6.427
复制
发表时间:
1995
影响因子:
2.5
通讯作者:
Mash,DC
中科院分区:
文献类型:
--
作者:
Hearn,WL;Pablo,J;Hime,GW;Mash,DC
This report describes a sensitive method for quantitating ibogaine and a single major metabolite in biological fluids and brain tissue. We identified the metabolite as 12-hydroxy-ibogamine (12-OH-ibogamine or noribogaine) by full-scan, electron-impact gas chromatography-mass spectrometry (GC-MS). Ibogaine, 12-OH-ibogamine, ando-(methyl)-ibogaine-d3(ibogaine-d3) internal standard were isolated by solvent extraction under basic conditions. The resulting organic extract was evaporated to dryness, and the residue was derivatized at room temperature with ethyl iodide in the presence of trimethyl anilinium hydroxide in dimetbyl sulfoxide. The reaction was terminated by acidification and washed with organic solvents to remove impurities. The aqueous phase was then alkalinized and reextracted. The organic extract was concentrated and analyzed by GC-MS. Quantitation was based upon the ratios of the molecular ions atm/z310 for ibogaine,m/z313 for ibogaine-d3, andm/z324 for 12-OH-ibogamine ethyl ether. The limit of detection was 5 ng/mL for both ibogaine and derivatized 12-OH-ibogamine, and limits of quantitation were between 5 and 10 ng/mL for all matrices tested. Calibration curves were linear in the range of 5–1000 ng/mL or ng/g for both analytes.